Evdokia F. Luginova

Evdokia F. Luginova

Auto-generated profile, based on publicly available information

Evdokia F. Luginova

Scientific and Practical Center “Phthisiology”; Medical Institute of the M.K. Ammosov North-Eastern Federal University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2022 in Tuberculosis and Lung Diseases
Verified
Journal Article
Open access
PDF file
OBO. D. Baronova
O. D. Baronova
VAV. A. Aksenova
V. A. Aksenova
ELE. F. Luginova
E. F. Luginova
EDE. N. Dolzhenko
E. N. Dolzhenko
The objective: to compare efficacy of preventive treatment of children with latent tuberculosis infection using various regimens of anti-tuberculosis drugs and assess the risk of adverse events to these drugs.Subjects and Methods. 117 children of 2-17 years old with latent tuberculosis infection [a positive result of the test with tuberculous recombinant allergen (TRA)] were enrolled in the prospective study. They received preventive treatment with the regimen containing isoniazid and rifapentine. The comparison group included 84 children who received isoniazid and rifampicin.Results. In terms of safety and efficacy of chemotherapy regimens in the study, the best results were obtained when using the regimen containing isoniazid and rifapentine: the therapy was well tolerated, hepatotoxic reactions were registered in 1.7% of children. After a full course of preventive treatment in 24 months of follow-up, there was a statistically significant decrease in the proportion of hyperergic results of the skit test with TRA from 44 (41.9%) to 0 (0%) χ2 McNemar 43.00; p < 0.01; and conversion of the TRA test result from positive to negative was observed in 18.1% of children.

30 November 2018 in Russian Open Medical Journal
Verified
Journal Article
Open access
ELEvdokia F. Luginova
Evdokia F. Luginova
Introduction Fight against tuberculosis (TB) or TB control is still among the world’s major objectives, and, as such, is driving the main focus areas of global public health [1]. The action planning by health services is based on clear understanding of the TB prevalence. Accumulation and analysis of key epidemiologic indicators describing the scale and size of the problem of TB serves as yet another mechanism, using which the spread of TB can be further contained within a region, a country, or the world [2].

17 January 2023 in Pacific Medical Journal
Verified
Journal Article
Open access
PDF file
ELE. F. Luginova
E. F. Luginova
DND. A. Nikolaeva
D. A. Nikolaeva
OGO. I. Guryeva
O. I. Guryeva
ENE. A. Nikiforova
E. A. Nikiforova
This paper presents a clinical case of a favorable tuberculosis chemotherapy outcome in a premature newborn. The role of early diagnosis in the development and outcome of the disease is shown. The newborn had no specific symptoms and clinical signs of tuberculosis. Therefore, when signs of an infectious disease appear in newborns, account should be taken of the mother’s medical history and the results of her fluorographic examination after childbirth. A favorable outcome can be achieved by timely separation of newborns from infected mothers, prompt commencement of specific chemotherapy, and patient management by phthisiatricians, neonatologists, and resuscitators.